Growth hormone release inhibiting hormone: neuropharmacological studies.
D000161:Acoustic Stimulation; D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004357:Drug Synergism; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010293:Pargyline / Q000494:pharmacology; D010907:Pituitary Hormones / Q000494:pharmacology*; D012640:Seizures; D012701:Serotonin / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D010907:Pituitary Hormones; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D013007:Growth Hormone-Releasing Hormone; D010293:Pargyline; D007099:Imipramine